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Abstract 
Background: Accurate measurement of clinical laboratory parameters plays an essential role in the correct 
interpretation of clinical biochemistry abnormalities. The purpose of this study was evaluation the time and 
temperature effect on HDLᵼ-C, HDL₂-C and HDL₃-C stability during storage. Materials and Methods: 50 adult 
healthy subjects were participated. For the isolation of HDLᵼ-C, we used precipitation method and HDLᵼ-C data was 
analyzed by the Abell-Kendal cholesterol reference method. The remaining serum were dispensed into 12 sample 
tubes and divided into two groups. One of each group was stored upright at room temperature (approximately 25 ºC) 
while another at 4 ºC and the half of each group tubes were received p-chloro-mercuriphenylsulfonic acid (PCMPS). 
The stored serum aliquots from all temperature and time points were analyzed on 1, 2, 3 days post collection. 
Results: HDLᵼ-C concentration at the temperature of room in 24 hours is not changed significantly but over the time 
decreased (7.2% in 3 days). In addition of PCMPS inhibitor, the concentration is increased  by 17.3% in 3 days. But 
in 4ºC, with or without PCMPS, there is no a significant change in the HDLᵼ-C concentration. HDL₃-C was found to 
be the most stable lipoprotein studied because of non-significant effect of storage time and temperature on it. 
Conclusion: The results suggest 4ºC as the ideal storage condition for the preservation of human serum samples for 
HDLᵼ-C assay. Also it is suggested that HDL concentration estimation should be performed in the first 24 hours of 
samples collection. PCMPS addition didn’t affect HDL subtypes concentration in 4ºC. 
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Cardiovascular diseases (CVDs) are one of the  
important  cause of death in the world (1). CVDs are 
responsible for about 17.7 million deaths in 2015, 
representing 31% of all global deaths. Of these 
deaths, an estimated 7.4 million were due to coronary 
heart disease and 6.7 million were due to stroke. 
Also, the number of people, who die from CVDs, 
mainly from heart disease and stroke, will increase to 
reach 23.3 million by 2030 (2). About 50% of annual 
deaths are related to this group of diseases in Iran (3).  
Among the variables involved in determining of  
the CVDs, Dyslipidemias characterized by disorders in 
the levels of circulating lipids, are important due to 
correlation with excessive caloric ingestion, with high 
rate of fat and total cholesterol (TC) and fraction 
cholesterol of low-density lipoprotein (LDL-C) (4). 
Diminished fraction of high density lipoprotein 
cholesterol (HDL-C), hypertension, smoking, diabetes 
and obesity are associated to advanced atherosclerosis 
lesions and a greater risk of clinical manifestations of 
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atherosclerotic disease (5). So nowadays, lipid profile 
is one of the most prescribed laboratory tests 
worldwide. 
According to the particle size, HDL-C can be 
divided into 10 subtypes (HDL₁-HDL₁₀) using 
lipoprint HDL analyzer, 1-3 types were large particle 
types (HDL-L), 4-7 types were intermediate particle 
types (HDL-M), and 8-10 types were small particle 
types (HDL-S). HDL-L may be protected factor for 
atherosclerosis, whose decrease was closely related 
with the increase of risk of chronic heart disease (6). 
Other studies suggest high density lipoprotein sub 
fractions difference in relationship with 
atherosclerosis (7). 
Despite advances in clinical chemistry testing, 
poor blood sample quality continues to impact 
laboratory operations and the quality of results (8). 
Sol F. Green demonstrates that pre-analytical 
errors are a significant financial burden to total 
hospital costs.  Pre-analytical errors not only increase 
redraw costs within the laboratory, but also impact 
on the time and resources required for follow-up or 
delays in patient care (9). How do we prevent or 
reduce these errors and conserve valuable resources? 
Studies showed collection, storage and 
transport of samples as pre-analytical factors in 
quality of laboratory tests (10). 
Although many investigations have been 
undertaken on the stability of proteins and lipids, but 
the results are widely divergent. According to the 
MONICA Manual, isolation of HDL and TC should 
preferably be done on fresh serum aliquots on the 
day of blood collection (11) while in the UK 
National Health Surveys, the samples were 
dispatched immediately after blood taking (12). 
LCAT (Lecithin Cholesterol Acyltransferase) 
is an enzyme which converts FC (Free Cholesterol) 
to EC (Esterified Cholesterol) and HDLᵼ-C to HDL₃-
C. This enzyme plays a key role in the HDL 
metabolism (13). 
Hence, the present study intends to  evaluate 
the effect of storage time and temperature and p-
chloro-mercuriphenylsulfonic acid (PCMPS) as 
LCAT enzyme inhibitor on the measured density of 
HDL₃-C and HDLᵼ-C in the samples of human serum 




Sample collection. 50 adult healthy persons 
(All men and with age between  45-55) were 
participated. All subjects had been fasting for 12 hrs. 
Blood samples (50 ml) were collected from antecubital 
vein using sterile needles (18 gauge) directly into 
clean dry sterile glass tubes without anticoagulant. 
Serum (20 ml) was harvested after 30 minutes 
following clot formation and by centrifugation for 10 
minutes at 2000 rpm. 
Isolation of HDL-C. HDLᵼ-C measurements 
are performed after first removing of  the other 
lipoproteins (VLDL-C and LDL-C) from the sampleS 
by heparin-Mn++ precipitation (14). The HDLᵼ-C in 
the supernatant was analyzed by the Abell-Kendal 
cholesterol reference method (15). “HDL-C” was 
precipitated by addition of Dextran Sulfate solution. 
After thorough mixing, the sample was left at room 
temperature for 20 min, and then was centrifuged for 
30 min at 4°C at 2700 rpm. An aliquot of the 
supernatant was used for cholesterol analysis (HDL₃-
C). The difference between total HDL cholesterol and 
“HDL₃” cholesterol represented HDL₂-C (16). 
Measurement. The remaining serum were 
dispensed into 12 sample tubes, closed tightly and 
divided into two groups. One of each group was stored 
upright at room temperature (approximately 25 ºC) 
while another was stored at 4 ºC and the half of each 
group tubes were received PCMPS (0.01 mg/dl). The 
stored serum aliquots from all temperature and time 
points were analyzed on 1, 2, 3 days’ post collection. 
Ethics. Informed consent was obtained from all 
human adult participants. The protocols of the current 
study were approved by ethics committee of Tehran 
University of Medical Sciences (No.1396.3408). 
Statistical analysis. To test the significant 
differences in concentration between storage 
temperatures and to assess the significant trends over 
time at each temperature, the data was analyzed 
statistically using non-parametric Friedman test for 
repeated-measures to examine the influence of storage 
time. Finding the significant differences (P < 0.05), 
Wilcoxon signed-rank test was used for those groups. 
Post-hoc analysis was conducted with a Bonferroni 
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correction applied, resulting in a significance level 
set at P < 0.017 (0.05/3 = 0.0166). To determine the 
clinically significant variations the percentage 
relative bias from the baseline sample was calculated 
by the formula: [(Cn-C1)/C1)] × 100.  (C1: the 
median result of the T₀ sample, Cn: the median result 
of the stored sample). Percentage relative bias for 
paired groups (T₀-T₁, T₀-T₂, T₀-T₃, etc.) was 
compared with the current analytical quality 
specifications for desirable bias taken from the 
Westgard QC (10), which was updated at 2014 by 
Ricos et al (17).  
Results 
The results of the present investigation at T₀ 
are presented in Table 1 along with the Intra-assay 
coefficient of variations determined at three levels 
for each analyte.  
The statistical analysis of serum +/- PCMPS 
under time and temperature effects is presented in 
Table 2 and 3. 
Time-course plots illustrate various stability 
situations are presented in Figure 1 and 2. 
Table1. Intra-assay coefficient of variations determined at three levels and T₀ (median and interquartile range) (mmol/L). 
Analyte  CV1 (%) Level1 CV2 (%) Level2 CV3 (%) Level3 Median (IQR) 
HDLᵼ-C 3.3 1.89 4.6 1.62 5.3 0.84 1.29 (0.61-2.03) 
HDL₃-C 4.6 0.68 6.2 1.26 6.8 1.57 0.9 (0.54-1.74) 
 
Table2. The time and temperature effects on the concentration (mmol/L) of HDLᵼ-C in samples during their storage with and 
without PCMPS. 
 Temperature       
                                ( ºC) 
Time(day)             
 
With PCMPS Without PCMPS Desired bias 




















































Figure 1. Time and temperature effects on the concentration of 
HDLᵼ-C (mg/dl). 
 
Figure 2. Time and temperature effects on the concentration of 
HDL₃-C (mg/dl). 
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HDLᵼ-C and HDL₃-C concentrations 
decreased markedly beginning from the first day to 
second day of storage in the serum (by 10.4% for 
HDLᵼ-C and 4.7% for HDL₃-C just in one day). In 
addition of LCAT inhibitor (PCMPS), the 
concentration began to increase (10.3% for HDL₃-C 
for first day and 17.3% for HDLᵼ-C over 3 days), But 
in 4ºC, with or without PCMPS, there isn’t 
significant change in the HDLᵼ-C and HDL₃-C 
concentration.   
Discussion 
Sample storage is one of the most effective 
factors in concentration of composite, especially lipid 
and lipoproteins which are metabolized fast and this 
fact influence laboratory results catastrophically. 
Therefore, we should pay attention to environmental 
factors and elements in blood that affect their 
metabolism. One of these factors in the blood is 
LCAT which is secreted into plasma by the liver and 
associates mostly with HDL-C, but also with LDL-C. 
It catalyzes the conversion of FC on the surface of 
lipoprotein particles to EC (Esterified Cholesterol). 
LCAT is also believed to be a key enzyme in the 
reverse cholesterol transport (RCT) pathway, because 
esterification of cholesterol on HDL-C increases the 
concentration gradient for the movement of FC  from 
cells onto HDL-C (18). HDL-C metabolism implies a 
continuous transfer of phospholipids from VLDL-C 
and IDL-C particles. A part of EC is transferred to 
chylomicrons and VLDL-C by cholesteryl ester 
transfer protein (CETP) activity. The combined action 
of LCAT and CEPT result HDL₃-C changes into 
HDL₂-C (13). Briefly, this enzyme has been seen in 
blood samples influences the concentration of FC, EC, 
HDLᵼ-C and HDL₃-C so in this study, we used the 
inhibitor of LCAT(PCMPS) to evaluate how it 
influence HDLᵼ-C and HDL₃-C stability for probable 
use of this enzyme in sample storage. 
HDLᵼ-C concentration at the temperature of 
room in 24 hours is not changed significantly but over 
the time decreased (7.2% in 3 days). Our observations 
were consistent with those of authors of similar studies 
(19,20,21). 
We revealed in 4ºC, with or without PCMPS, 
there is no significant change in the HDLᵼ-C 
concentration. Heins M et al. showed HDL-C tubes at 
4 ºC were stayed stable up to 36-h (22). Maduka 
Ignatius et al. reported non-significant changes up to 
48-h in serum and significant change from day 2-10 at 
4ºC (23). Heins et al. reported increases in HDL 
concentrations in plain serum, but found as stable at 9 
ºC (22). According above results, there are 
discrepancies between the results of other studies and 
the present study, it might be explained by differences 
in analytic methods, by different storage temperatures 
and assay intervals. 
Table3. The time and temperature effects on the concentration (mg/dl) of HDL₃-C in samples during their storage with and 
without PCMPS. 
         Temperature          
                    (ºC)                            
Time(day)                   
                                                  
With PCMPS Without PCMPS Desired bias 
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Although studies about PCMPS in Vitro 
kinetics are limited, but there are literatures about 
enzyme deactivation in decreased or increased 
temperatures (24). Hence, we can explain stable 
concentration of HDLᵼ-C with deactivation of 
PCMPS as an inhibitor of destructive enzyme of 
HDL under the effect of temperature.  
HDL₃-C was found to be the most stable  
studied lipoprotein because of non-significant effect 
of storage time and temperature on it. To compare 
with other studies Gao et al. emphasized that HDL₂-
C are remodeled faster and thus are less stable than 
HDL₃-C. They evaluated the reason and found that 
“the smaller the particle, the higher the rupture 
temperature and the slower the protein unfolding” 
(25). Therefore, smaller spherical HDL-C are more 
stable than their larger competitors. This fact 
reported here is consistent with study by Pownall and 
colleagues of HDL disruption by streptococcal serum 
opacity factor that causes HDL –C fusion and 
dissociation of a fraction of apoA-I. They showed 
that smaller HDL-C undergo slower disruption and 
fusion than their larger counterparts (26). 
Thus, increased propensity of HDL₂-C to fuse 
and rupture, together with increased affinity for HDL 
receptor (27) may contribute to preferential lipid 
uptake from these large particles over their smaller 
protein-rich counterparts (HDL₃-C) and cause 
reduced stability. 
There are two main limitations that need to be 
acknowledged regarding the present study. Because 
of time consuming nature of precipitation methods 
for HDL isolation and material limitation, we 
repeated measurements 3 times which supposed to be 
not enough for statistical evaluation. Therefore, we 
suggest studies with more repeated data for the better 
statistical significance. It was difficult  to select 
appropriate assay intervals, but we used previous 
studies in this way. We suggest studies with shorter 
assay intervals, because of  the fast change of 
lipoproteins. 
Conclusion 
 The results suggest 4ºC as the ideal storage 
condition for the preservation of human serum 
samples for HDLᵼ-C and HDL₃-C assay. Also it is 
suggested that HDLᵼ-C concentration estimation 
should be performed in the first day of samples 
collection. PCMPS addition didn’t affect HDLᵼ-C and 
HDL₃-C concentration in 4ºC. 
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